Share
Market Research Report

IPV VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Vaccine BrandPOLIOVAC (PFS/SD) · SHANIPV · POLIORIX · IPOL/IMOVAX · And POLYMILEX
  • By Distribution ChannelPrivate and Public
  • Published In29 Apr 2026
  • Report CodeCMI4965
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Vaccine Brand
      • Market Snapshot, By Vaccine Type
      • Market Snapshot, By Vial Type
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
      • Market Scenario - Conservative, Likely, Opportunistic
    • Market Opportunity Map
  3. Key Insights

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Pest Analysis
    • Porters Analysis
    • Company Market Share Analysis
    • Import-Export Analysis
    • Regulatory Scenario
    • Pricing Analysis
    • Epidemiology
    • Healthcare Spending, by Country
    • Vaccination Rate, by Country
    • Manufacturing Capacities
    • Distributors Landscape
    • Investments & Funding
    • Competitive Snapshot
    • Heat Map Analysis
  4. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2033 (US$ Million)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033
      • Market Y-o-Y Growth Comparison (%), 2021 - 2033
      • Segment Trends
    • POLIOVAC (PFS/SD), 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • SHANIPV, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • POLIORIX, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • IPOL/IMOVAX, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • POLYMILEX, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
  5. Global IPV Vaccines Market, By Vaccine Type, 2021 - 2033 (US$ Million)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033
      • Market Y-o-Y Growth Comparison (%), 2021 - 2033
      • Segment Trends
    • Combination Vaccine, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • Single Vaccine, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
  6. Global IPV Vaccines Market, By Vial Type, 2021 - 2033 (US$ Million)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033
      • Market Y-o-Y Growth Comparison (%), 2021 - 2033
      • Segment Trends
    • 1 Dose Vial, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • 5 Dose Vial, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • 10 Dose Vial, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
  7. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2033 (US$ Million)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033
      • Market Y-o-Y Growth Comparison (%), 2021 - 2033
      • Segment Trends
    • Public, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
    • Private, 2021 - 2033(US$ Million)
      • Introduction
      • Market Size and Forecast, 2021 - 2033, (US$ Million)
  8. Global IPV Vaccines Market, By Region, 2021 - 2033 (US$ Million)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, (US$ Million)
      • Market Y-o-Y Growth Comparison (%), 2026 - 2033, (US$ Million)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest Of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • Asean
        • Rest Of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
        • GCC
        • Israel
        • Rest Of The Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (US$ Million)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Competitive Snapshot
    • What Market Participants are Saying?
    • Competitive Dashboard
    • Company Market Share Analysis, 2026 - Global
  10. Company Profiles - Global IPV Vaccines Market

    • Sanofi*
      • Company Overview
      • Product/Service Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategic Overview
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Merck & Co., Inc.
    • GlaxoSmithKline
    • AJ Vaccines A/S
    • Panacea Biotec
    • Biken
    • Sinopharm Group Co. Ltd.
    • Nanolek
    • IMBCAMS
    • Sinovac Biotech
    • LG Chem
    • Beijing Minhai Biological Technology Co., Ltd.
    • Biological E Limited.
    • Section 10: Wheel of Fortune
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact